Medicenna Therapeutics Corp. (MDNA.TO) TSX
Currency In CAD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 53.24M |
| Enterprise Value | 47.11M |
| P/E Ratio | -1.86 |
| PEG Ratio | 0.06 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | 21.23 |
| Enterprise/Revenue | 0 |
| Enterprise/EBITDA | -1.14 |
Fiscal Year
| Fiscal Year | March 31, 2026 |
| Most Recent Quarter | June 30, 2026 |
Profitability
| Profit Margin | 0 |
| Operating Margin | 0 |
AD
Management Effectiveness
| Return On Assets | -2.25 |
| Return On Equity | -3.6 |
Income Statement
| Revenue | 0 |
| Revenue/Share | 0 |
| Gross Profit | -77,000 |
| EBITDA | -23.63M |
| Net Income | -18.41M |
| Diluted EPS | -0.22 |
Balance Sheet
| Total Cash | 5.69M |
| Total Cash/Share | 0.07 |
| Total Debt | 104,000 |
| Total Debt/Equity | 0.06 |
| Current Ratio | 1.25 |
| Book Value Per Share | 0.02 |
Price History
| 52-Week Change | -62.73 |
| 52-Week High | 1.97 |
| 52-Week Low | 0.34 |
| Moving Average 50 Days | 0.39 |
| Moving Average 200 Days | 0.75 |
Statistics
| Average Volume | 63,719 |
| Shares Outstanding | 77.62M |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |
AD
